E. Cretton‐Scott

Pharmacology of β- <scp>l</scp> -Thymidine and β- <scp>l</scp> -2′-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus

Brenda I. Hernández-Santiago, L Placidi, E. Cretton‐Scott et al. · Antimicrobial Agents and Chemotherapy · 2002 · 52 citations · Full text

Disposition and metabolism of the angiogenic moderator O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470) in human hepatocytes and tissue microsomes.

L Placidi, E. Cretton‐Scott, Georges de Sousa et al. · PubMed · 1995 · 40 citations

Lipid Peroxidation, Secondary Metabolite, Extensive Metabolism +19

Synthesis, Biotransformation, and Pharmacokinetic Studies of 9-(β-<scp>d</scp>-Arabinofuranosyl)-6-azidopurine:  A Prodrug for Ara-A Designed To Utilize the Azide Reduction Pathway

Lakshmi P. Kotra, Konstantine K. Manouilov, E. Cretton‐Scott et al. · Journal of Medicinal Chemistry · 1996 · 39 citations

588 IN VITRO ANTIVIRAL ACTIVITY AND PHARMACOLOGY OF IDX184, A NOVEL AND POTENT INHIBITOR OF HCV REPLICATION

E. Cretton‐Scott, Christian Périgaud, Suzanne Peyrottes et al. · Journal of Hepatology · 2008 · 33 citations

Neurovirology, Viral Polymerase Mechanism, Immunology +7

NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzee

David N. Standring, Robert E. Lanford, Teresa L. Wright et al. · Journal of Hepatology · 2003 · 18 citations

Nm 283, Hepatitis C, Viral Hepatitis +10